Understanding how FMRP affects brain development and finding new treatments for Fragile X syndrome
FMRP-mediated Regulation in Human Brain Development and Therapeutic Advancement
This study is looking at how a protein called FMRP affects brain development and aims to find better treatments for Fragile X syndrome, so that people with this condition can have more effective options for managing their symptoms.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11179530 on NIH RePORTER |
What this research studies
This research investigates the role of the fragile X mental retardation protein (FMRP) in brain development and its implications for treating Fragile X syndrome (FXS). By utilizing advanced human cell culture techniques, including 3D organoid models, the project aims to better understand the molecular mechanisms disrupted in FXS. The research also explores potential therapeutic approaches that could correct these disruptions, building on previous findings from animal models. Patients may benefit from insights that lead to more effective treatments for FXS.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are individuals diagnosed with Fragile X syndrome or those with a family history of the condition.
Not a fit: Patients without Fragile X syndrome or related genetic conditions may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies for individuals with Fragile X syndrome, enhancing their quality of life.
How similar studies have performed: Previous research using animal models has shown promise, but this approach using human-derived models is relatively novel and untested in clinical settings.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Jin, Peng — Emory University
- Study coordinator: Jin, Peng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.